Form 4: Elanco Executive Ramiro Martin Cabral Reports Stock Transactions
SEC Form 4 Filing
Elanco Animal Health's Executive Vice President, Ramiro Martin Cabral, reports the acquisition and disposal of company stock.
Summary
- On February 19, 2025, Ramiro Martin Cabral, an Executive Vice President at Elanco Animal Health Inc., reported transactions involving Elanco's common stock.
- Cabral acquired 68,214 shares of common stock at $0.
- He also disposed of 30,093 shares at a price of $11.24 per share.
- Following these transactions, Cabral directly owns 207,169 shares of Elanco common stock.
Sentiment
Score: 5
Explanation: This is a neutral filing, simply reporting stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the Securities and Exchange Act. It provides transparency into insider activity but doesn't necessarily indicate broader industry trends.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| May 14, 2024 | Date of Power of Attorney granted by Ramiro M. Cabral. |
| February 19, 2025 | Date of stock acquisition and disposal transactions. |
| February 21, 2025 | Date of signature for the Form 4 filing. |
Keywords
Elanco Animal Health, Ramiro Martin Cabral, Form 4, Stock Transaction, Beneficial Ownership, Securities Exchange Act, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.